UBS Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.43M | Buy |
363,848
+315,089
| +646% | +$6.43M | ﹤0.01% | 2705 |
|
2025
Q1 | $976K | Sell |
48,759
-763,841
| -94% | -$15.3M | ﹤0.01% | 4205 |
|
2024
Q4 | $21.7M | Buy |
812,600
+758,466
| +1,401% | +$20.2M | ﹤0.01% | 1692 |
|
2024
Q3 | $1.54M | Buy |
54,134
+5,411
| +11% | +$154K | ﹤0.01% | 3233 |
|
2024
Q2 | $1.06M | Sell |
48,723
-6,120
| -11% | -$133K | ﹤0.01% | 3361 |
|
2024
Q1 | $1.21M | Buy |
54,843
+13,366
| +32% | +$296K | ﹤0.01% | 3414 |
|
2023
Q4 | $895K | Buy |
41,477
+23,436
| +130% | +$506K | ﹤0.01% | 3522 |
|
2023
Q3 | $305K | Buy |
18,041
+736
| +4% | +$12.4K | ﹤0.01% | 3959 |
|
2023
Q2 | $237K | Buy |
17,305
+6,731
| +64% | +$92.3K | ﹤0.01% | 4343 |
|
2023
Q1 | $240K | Buy |
10,574
+89
| +0.8% | +$2.02K | ﹤0.01% | 4219 |
|
2022
Q4 | $247K | Buy |
10,485
+3,354
| +47% | +$79K | ﹤0.01% | 4222 |
|
2022
Q3 | $186K | Sell |
7,131
-9,094
| -56% | -$237K | ﹤0.01% | 4127 |
|
2022
Q2 | $356K | Buy |
16,225
+12,376
| +322% | +$272K | ﹤0.01% | 3583 |
|
2022
Q1 | $173K | Sell |
3,849
-6,549
| -63% | -$294K | ﹤0.01% | 4489 |
|
2021
Q4 | $446K | Buy |
10,398
+9,142
| +728% | +$392K | ﹤0.01% | 4061 |
|
2021
Q3 | $83K | Buy |
1,256
+576
| +85% | +$38.1K | ﹤0.01% | 4875 |
|
2021
Q2 | $50K | Sell |
680
-8,497
| -93% | -$625K | ﹤0.01% | 5365 |
|
2021
Q1 | $628K | Sell |
9,177
-1,966
| -18% | -$135K | ﹤0.01% | 3765 |
|
2020
Q4 | $748K | Buy |
11,143
+7,121
| +177% | +$478K | ﹤0.01% | 3364 |
|
2020
Q3 | $206K | Sell |
4,022
-2,229
| -36% | -$114K | ﹤0.01% | 3968 |
|
2020
Q2 | $236K | Sell |
6,251
-432
| -6% | -$16.3K | ﹤0.01% | 3891 |
|
2020
Q1 | $199K | Buy |
6,683
+1,490
| +29% | +$44.4K | ﹤0.01% | 3898 |
|
2019
Q4 | $178K | Buy |
5,193
+2,383
| +85% | +$81.7K | ﹤0.01% | 4663 |
|
2019
Q3 | $51K | Buy |
+2,810
| New | +$51K | ﹤0.01% | 5247 |
|